Available Reports

Profitability Soars with 490 Bps MLR Improvement; Full-Year Guidance Reaffirmed on Strong Start to 2026 FY2026 Q1 | Jun 04, 2026

Guides to $18.7B-$19.0B in 2026 Revenue and a Return to Profitability After Record Enrollment Drives Market Share to 30% FY2025 Q4 | Feb 11, 2026

FY25 Guidance Reaffirmed; Focus Shifts to 2026 with ~28% Rate Increase to Restore Profitability FY2025 Q3 | Nov 14, 2025

Profitability Guidance Lowered on Market-Wide Morbidity Shift; Company Raises 2026 Rates and Cuts Costs FY2025 Q2 | Nov 14, 2025

Revenue Surges 42% and SG&A Hits Record Low; Full-Year Guidance Reaffirmed Amidst Shifting Medical Trends FY2025 Q1 | Nov 14, 2025

Achieves First Full-Year Profitability; 2025 Guidance Projects Continued Margin Expansion on 1.8M Paid Member Base FY2024 Q4 | Nov 14, 2025

Guidance Upgraded to Full-Year Net Income Profitability as Revenue Surges 68% FY2024 Q3 | Nov 14, 2025

Revenue and Adjusted EBITDA Guidance Raised on Robust Membership Growth FY2024 Q2 | Nov 14, 2025

Achieves First-Ever Net Income Profitability Driven by 46% Revenue Growth and Margin Expansion FY2024 Q1 | Nov 14, 2025

Pivots to Profitable Growth, Guiding to $125M-$175M Adj. EBITDA in 2024 on Strong Membership Rebound to 1.3M+ FY2023 Q4 | Nov 14, 2025

Profitability Outlook Substantially Raised on Improved Underwriting; 2024 Target Reaffirmed FY2023 Q3 | Nov 14, 2025

Full-Year Adjusted EBITDA Outlook Improved on Sustained Profitability; 2024 Growth Strategy Centers on Rural Market Expansion FY2023 Q2 | Nov 14, 2025

Q1 Profitability Milestone Reached as Focus Shifts to Disciplined 2024 Growth Re-acceleration FY2023 Q1 | Nov 14, 2025

Path to 2024 Profitability De-Risked as 2023 Guidance Targets InsuranceCo Breakeven FY2022 Q4 | Nov 14, 2025

Profitability Timeline Accelerated to 2024, Supported by Management Restructuring and $120M in Cost Savings FY2022 Q3 | Nov 14, 2025

Guidance Reaffirmed as +Oscar Strategy Pivots to Prioritize 2023 InsuranceCo Profitability FY2022 Q2 | Nov 14, 2025

Membership Surpasses 1 Million as Focus Sharpens on 2023 Profitability and +Oscar Evolves to SaaS Model FY2022 Q1 | Nov 14, 2025

Membership Surges 49%, Fueling >80% Premium Growth Guidance for 2022 and Reaffirming 2023 Profitability Target FY2021 Q4 | Nov 14, 2025

Profitability Soars with 490 Bps MLR Improvement; Full-Year Guidance Reaffirmed on Strong Start to 2026

Sign in required

dbot

Oscar Health Inc - Reports

Available Reports

Profitability Soars with 490 Bps MLR Improvement; Full-Year Guidance Reaffirmed on Strong Start to 2026

Sign in required